{"id":319380,"date":"2026-10-21T11:47:54","date_gmt":"2026-10-21T06:17:54","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=319380"},"modified":"2026-10-21T11:47:54","modified_gmt":"2026-10-21T06:17:54","slug":"largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/","title":{"rendered":"4 Largecap Stocks Valued Between Rs 3 and Rs 5 Lakh Crore to Watch for Future Multibagger Potential: Sun Pharma, Adani Ports, Titan and HAL"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Sun Pharma Rs 1,743. Adani Ports Rs 1,766. Titan Rs 4,424.20. HAL Rs 4,959. Market caps from Rs 3.33 lakh crore to Rs 4.22 lakh crore. Data as of 20 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Sun Pharma, Adani Ports, Titan and HAL are the 4 picks in this stocks valued between Rs 3 and Rs 5 lakh crore watchlist, with market caps between Rs 3.33 lakh crore and Rs 4.22 lakh crore. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22, while Adani Ports offers the lowest PE of the group at 30.69. PE ratios run from 30.69 to 68.51, so compare each one with its industry PE before investing. All figures are as of 20 October 2026.<\/p>\n<\/p><\/div>\n<p>Stocks valued between Rs 3 and Rs 5 lakh crore to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Sun Pharma, Adani Ports, Titan and HAL meet that test, with market caps from Rs 3.33 lakh crore to Rs 4.22 lakh crore and Sun Pharma offering the fastest profit growth, 35.75% a year since FY22. Companies worth Rs 3 lakh crore to Rs 5 lakh crore are among the largest listed businesses in India, yet they still report double-digit growth in several cases.<\/p>\n<p>This list covers companies with a market cap between Rs 3 lakh crore and Rs 5 lakh crore, rising profit and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening stocks valued between Rs 3 and Rs 5 lakh crore usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 20 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=stocks-valued-between-rs-and-rs-lakh-crore\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#What_Are_Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Stocks Valued Between Rs 3 and Rs 5 Lakh Crore and Why Do They Attract Multibagger Interest?\">What Are Stocks Valued Between Rs 3 and Rs 5 Lakh Crore and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Stocks Valued Between Rs 3 and Rs 5 Lakh Crore at a Glance: Price, Market Cap, PE and ROE\">Stocks Valued Between Rs 3 and Rs 5 Lakh Crore at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Sun_Pharma_3575_Profit_CAGR_Since_FY22\" title=\"Sun Pharma: 35.75% Profit CAGR Since FY22\">Sun Pharma: 35.75% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Adani_Ports_2674_Profit_CAGR_Since_FY22\" title=\"Adani Ports: 26.74% Profit CAGR Since FY22\">Adani Ports: 26.74% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Titan_2326_Profit_CAGR_Since_FY22\" title=\"Titan: 23.26% Profit CAGR Since FY22\">Titan: 23.26% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#HAL_Return_on_Equity_of_2221\" title=\"HAL: Return on Equity of 22.21%\">HAL: Return on Equity of 22.21%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore_Financial_Comparison_on_Growth_and_Margins\" title=\"Stocks Valued Between Rs 3 and Rs 5 Lakh Crore: Financial Comparison on Growth and Margins\">Stocks Valued Between Rs 3 and Rs 5 Lakh Crore: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Institutional_Holding_in_Sun_Pharma_Adani_Ports_Titan_and_HAL\" title=\"Institutional Holding in Sun Pharma, Adani Ports, Titan and HAL\">Institutional Holding in Sun Pharma, Adani Ports, Titan and HAL<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore\" title=\"Risks to Weigh in Stocks Valued Between Rs 3 and Rs 5 Lakh Crore\">Risks to Weigh in Stocks Valued Between Rs 3 and Rs 5 Lakh Crore<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#How_to_Choose_Between_Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore\" title=\"How to Choose Between Stocks Valued Between Rs 3 and Rs 5 Lakh Crore\">How to Choose Between Stocks Valued Between Rs 3 and Rs 5 Lakh Crore<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore_to_Watch\" title=\"Frequently Asked Questions on Stocks Valued Between Rs 3 and Rs 5 Lakh Crore to Watch\">Frequently Asked Questions on Stocks Valued Between Rs 3 and Rs 5 Lakh Crore to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Which_are_the_best_stocks_valued_between_Rs_3_and_Rs_5_lakh_crore_to_watch_for_multibagger_potential\" title=\"Which are the best stocks valued between Rs 3 and Rs 5 lakh crore to watch for multibagger potential?\">Which are the best stocks valued between Rs 3 and Rs 5 lakh crore to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Is_Titan_a_good_stock_for_long-term_investors\" title=\"Is Titan a good stock for long-term investors?\">Is Titan a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Can_Sun_Pharma_become_a_multibagger_from_here\" title=\"Can Sun Pharma become a multibagger from here?\">Can Sun Pharma become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Sun_Pharma_Adani_Ports_Titan_and_HAL\" title=\"What is the market cap of Sun Pharma, Adani Ports, Titan and HAL?\">What is the market cap of Sun Pharma, Adani Ports, Titan and HAL?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_stocks_valued_between_Rs_3_and_Rs_5_lakh_crore\" title=\"What are the risks of investing in stocks valued between Rs 3 and Rs 5 lakh crore?\">What are the risks of investing in stocks valued between Rs 3 and Rs 5 lakh crore?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#Why_is_Titan_trading_at_a_PE_of_6851\" title=\"Why is Titan trading at a PE of 68.51?\">Why is Titan trading at a PE of 68.51?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Sun_Pharma_Adani_Ports_Titan_and_HAL\" title=\"How much do institutions hold in Sun Pharma, Adani Ports, Titan and HAL?\">How much do institutions hold in Sun Pharma, Adani Ports, Titan and HAL?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Stocks Valued Between Rs 3 and Rs 5 Lakh Crore and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Stocks valued between Rs 3 and Rs 5 lakh crore are shares of companies that sit just below the very top of the Indian market. They are large enough for mutual funds and foreign investors to hold in size, and each has a clear business engine behind its growth. Together, stocks valued between Rs 3 and Rs 5 lakh crore show how large companies can keep growing.<\/p>\n<p>Companies in this range often have deep liquidity, long track records and strong brands or franchises. Among stocks valued between Rs 3 and Rs 5 lakh crore, those that keep growing profit on a large base are the ones investors compare in stocks valued between Rs 3 and Rs 5 lakh crore. This guide looks at stocks valued between Rs 3 and Rs 5 lakh crore using FY26 results and the latest quarterly numbers. Every one of stocks valued between Rs 3 and Rs 5 lakh crore below has complete, verifiable data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Stocks Valued Between Rs 3 and Rs 5 Lakh Crore at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 20 October 2026. Adani Ports has the lowest PE of the group at 30.69, while Titan posts the highest return on equity at 32.31%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,743<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,22,427<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.86<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,583.70 to 2,046.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/adaniports\/adani-ports-and-special-economic-zone-ltd-share-price-today\">Adani Ports and Special Economic Zone<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,766<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,02,686<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">30.69<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.83<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.32%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.66<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,292.00 to 1,891.10<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/titan\/titan-company-ltd-share-price-today\">Titan Company<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,424.20<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,94,621<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">68.51<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">46.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.31%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.93<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,506.50 to 5,186.70<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hal\/hindustan-aeronautics-ltd-share-price-today\">Hindustan Aeronautics<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,959<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,33,050<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">35.73<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">48.59<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.21%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.00<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,479.10 to 5,149.90<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_3575_Profit_CAGR_Since_FY22\"><\/span><strong>Sun Pharma: 35.75% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharmaceutical Industries is one of India&#8217;s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 34.86 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Adani_Ports_2674_Profit_CAGR_Since_FY22\"><\/span><strong>Adani Ports: 26.74% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Adani Ports and Special Economic Zone is India&#8217;s largest private port operator, with ports on both coasts and a growing logistics business. It reported FY26 revenue of Rs 40,854.36 crore, up 26.16% year on year, and net profit of Rs 12,782.03 crore, up 15.56%. Net profit has compounded at 26.74% a year since FY22, while revenue has grown 20.55% a year. Operating margin was 64.59% in FY26.<\/p>\n<p>The stock trades at a PE of 30.69 against an industry PE of 31.83, below the sector average, with a return on equity of 13.32%. In the June 2026 quarter, revenue rose 23.90% to Rs 11,673.71 crore and net profit grew 10.24% to Rs 3,649.50 crore. The share price has gained 115.30% over five years and 17.95% over the past year. Foreign investors raised their holding from 13.61% in September 2025 to 15.95% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Titan_2326_Profit_CAGR_Since_FY22\"><\/span><strong>Titan: 23.26% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Titan Company runs the jewellery (Tanishq), watches (Titan), eyewear and fragrances businesses. It reported FY26 revenue of Rs 88,136 crore, up 44.62% year on year, and net profit of Rs 5,073 crore, up 52.02%. Net profit has compounded at 23.26% a year since FY22, while revenue has grown 32.00% a year. Operating margin was 10.06% in FY26.<\/p>\n<p>In the June 2026 quarter, revenue rose 29.31% to Rs 21,502 crore and net profit grew 62.88% to Rs 1,777 crore. The share price has gained 72.39% over five years and 22.47% over the past year. Domestic institutions raised their holding from 12.78% in June 2025 to 15.34% in June 2026. The stock trades at a PE of 68.51 against an industry PE of 46.75, with a return on equity of 32.31%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"HAL_Return_on_Equity_of_2221\"><\/span><strong>HAL: Return on Equity of 22.21%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Hindustan Aeronautics is India&#8217;s state-owned aerospace company that designs, makes and services fighter jets, helicopters, engines and avionics. It reported FY26 revenue of Rs 36,787.95 crore, up 9.68% year on year, and net profit of Rs 9,115.52 crore, up 8.98%. Net profit has compounded at 15.74% a year since FY22, while revenue has grown 9.48% a year. Operating margin was 40.89% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 35.73 against an industry PE of 48.59, below the sector average, with a return on equity of 22.21%. In the June 2026 quarter, revenue rose 15.26% to Rs 6,415.41 crore and net profit grew 14.88% to Rs 1,589.66 crore. The share price has gained 607.71% over five years. Domestic institutions raised their holding from 8.71% in September 2025 to 12.56% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Stocks Valued Between Rs 3 and Rs 5 Lakh Crore: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these stocks valued between Rs 3 and Rs 5 lakh crore. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Net Profit CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">61,673.94<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,564.52<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">35.75%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.52%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Adani Ports<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">40,854.36<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12,782.03<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">26.16%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.55%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">26.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">65.67%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Titan<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">88,136<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,073<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">44.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.00%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.26%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">HAL<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36,787.95<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9,115.52<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.48%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">44.22%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these stocks valued between Rs 3 and Rs 5 lakh crore<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Sun_Pharma_Adani_Ports_Titan_and_HAL\"><\/span><strong>Institutional Holding in Sun Pharma, Adani Ports, Titan and HAL<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these stocks valued between Rs 3 and Rs 5 lakh crore alongside the promoter. The table uses the latest reported quarter for each. Sun Pharma has the deepest institutional backing, with FII and DII together holding 36.63% as of September 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%), Titan (from 12.78% to 15.34%) and HAL (from 8.71% to 12.56%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.27%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.70%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Adani Ports<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">66.03%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.95%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.25%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.77%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Titan<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.90%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.34%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">HAL<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">71.64%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.56%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore\"><\/span><strong>Risks to Weigh in Stocks Valued Between Rs 3 and Rs 5 Lakh Crore<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with stocks valued between Rs 3 and Rs 5 lakh crore means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Market cap changes every day with the share price.<\/li>\n<li>Growth may ease as the base gets larger.<\/li>\n<li><strong>Valuation:<\/strong> Titan trades at a PE of 68.51 against an industry PE of 46.75, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore\"><\/span><strong>How to Choose Between Stocks Valued Between Rs 3 and Rs 5 Lakh Crore<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from stocks valued between Rs 3 and Rs 5 lakh crore comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (31.83 to 48.59) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track quarterly profit growth, the return on equity and institutional holding in every result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Sun Pharma, Adani Ports, Titan and HAL live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among stocks valued between Rs 3 and Rs 5 lakh crore, Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22, Adani Ports for the lowest PE of the group at 30.69, Titan for the highest return on equity at 32.31% and HAL for the biggest five-year price gain at 607.71%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks valued between Rs 3 and Rs 5 lakh crore should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Stocks_Valued_Between_Rs_3_and_Rs_5_Lakh_Crore_to_Watch\"><\/span><strong>Frequently Asked Questions on Stocks Valued Between Rs 3 and Rs 5 Lakh Crore to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_stocks_valued_between_Rs_3_and_Rs_5_lakh_crore_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best stocks valued between Rs 3 and Rs 5 lakh crore to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma, Adani Ports, Titan and HAL are the 4 names this list highlights, with market caps of Rs 4,22,427 crore, Rs 4,02,686 crore, Rs 3,94,621 crore and Rs 3,33,050 crore respectively. Sun Pharma is notable for the fastest profit growth, 35.75% a year since FY22. Adani Ports stands out for the lowest PE of the group at 30.69. Titan offers the highest return on equity at 32.31%. HAL brings the biggest five-year price gain at 607.71%. These are watchlist names for stocks valued between Rs 3 and Rs 5 lakh crore, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Titan_a_good_stock_for_long-term_investors\"><\/span><strong>Is Titan a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Titan has a return on equity of 32.31%, a PE of 68.51 against an industry PE of 46.75 and a market cap of Rs 3,94,621 crore. Net profit has compounded at 23.26% a year since FY22, and FY26 revenue rose 44.62% while June 2026 quarter net profit grew 62.88%. Long-term returns in stocks valued between Rs 3 and Rs 5 lakh crore depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Sun_Pharma_become_a_multibagger_from_here\"><\/span><strong>Can Sun Pharma become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks valued between Rs 3 and Rs 5 lakh crore requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.86 against an industry PE of 36.42, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Sun_Pharma_Adani_Ports_Titan_and_HAL\"><\/span><strong>What is the market cap of Sun Pharma, Adani Ports, Titan and HAL?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 20 October 2026, Sun Pharma has a market cap of Rs 4,22,427 crore, Adani Ports has a market cap of Rs 4,02,686 crore, Titan has a market cap of Rs 3,94,621 crore and HAL has a market cap of Rs 3,33,050 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks valued between Rs 3 and Rs 5 lakh crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_stocks_valued_between_Rs_3_and_Rs_5_lakh_crore\"><\/span><strong>What are the risks of investing in stocks valued between Rs 3 and Rs 5 lakh crore?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Titan trades at a PE of 68.51 against an industry PE of 46.75, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Titan_trading_at_a_PE_of_6851\"><\/span><strong>Why is Titan trading at a PE of 68.51?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Titan&#8217;s PE of 68.51 compares with an industry PE of 46.75. The market is paying a premium for a return on equity of 32.31%, profit growth of 23.26% a year since FY22 and latest-quarter profit growth of 62.88%, which also means the stock is more sensitive if growth slows. Investors in stocks valued between Rs 3 and Rs 5 lakh crore who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Sun_Pharma_Adani_Ports_Titan_and_HAL\"><\/span><strong>How much do institutions hold in Sun Pharma, Adani Ports, Titan and HAL?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 29.20% of Adani Ports (15.95% and 13.25%), 30.72% of Titan (15.38% and 15.34%) and 21.98% of HAL (9.42% and 12.56%). Rising institutional holding is a useful signal in stocks valued between Rs 3 and Rs 5 lakh crore, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best stocks valued between Rs 3 and Rs 5 lakh crore to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma, Adani Ports, Titan and HAL are the 4 names this list highlights, with market caps of Rs 4,22,427 crore, Rs 4,02,686 crore, Rs 3,94,621 crore and Rs 3,33,050 crore respectively. Sun Pharma is notable for the fastest profit growth, 35.75% a year since FY22. Adani Ports stands out for the lowest PE of the group at 30.69. Titan offers the highest return on equity at 32.31%. HAL brings the biggest five-year price gain at 607.71%. These are watchlist names for stocks valued between Rs 3 and Rs 5 lakh crore, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Titan a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Titan has a return on equity of 32.31%, a PE of 68.51 against an industry PE of 46.75 and a market cap of Rs 3,94,621 crore. Net profit has compounded at 23.26% a year since FY22, and FY26 revenue rose 44.62% while June 2026 quarter net profit grew 62.88%. Long-term returns in stocks valued between Rs 3 and Rs 5 lakh crore depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Sun Pharma become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks valued between Rs 3 and Rs 5 lakh crore requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.86 against an industry PE of 36.42, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Sun Pharma, Adani Ports, Titan and HAL?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 20 October 2026, Sun Pharma has a market cap of Rs 4,22,427 crore, Adani Ports has a market cap of Rs 4,02,686 crore, Titan has a market cap of Rs 3,94,621 crore and HAL has a market cap of Rs 3,33,050 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks valued between Rs 3 and Rs 5 lakh crore.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in stocks valued between Rs 3 and Rs 5 lakh crore?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Titan trades at a PE of 68.51 against an industry PE of 46.75, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Titan trading at a PE of 68.51?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Titan's PE of 68.51 compares with an industry PE of 46.75. The market is paying a premium for a return on equity of 32.31%, profit growth of 23.26% a year since FY22 and latest-quarter profit growth of 62.88%, which also means the stock is more sensitive if growth slows. Investors in stocks valued between Rs 3 and Rs 5 lakh crore who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Sun Pharma, Adani Ports, Titan and HAL?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 29.20% of Adani Ports (15.95% and 13.25%), 30.72% of Titan (15.38% and 15.34%) and 21.98% of HAL (9.42% and 12.56%). Rising institutional holding is a useful signal in stocks valued between Rs 3 and Rs 5 lakh crore, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 largecap stocks valued between Rs 3 and Rs 5 lakh crore compared on market cap, PE, ROE, growth and institutional holding: Sun Pharma, Adani Ports, Titan and HAL.<\/p>\n","protected":false},"author":33,"featured_media":319379,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[13720,13721],"class_list":["post-319380","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-stocks-valued-between-rs-3-and-rs-5-lakh-crore","tag-stocks-valued-between-rs-3-and-rs-5-lakh-crore-sector"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["319379"],"rank_math_title":["Stocks Valued Between Rs 3 and Rs 5 Lakh Crore to Watch in 2026"],"rank_math_description":["Stocks valued between Rs 3 and Rs 5 lakh crore to watch for multibagger potential: Sun Pharma, Adani Ports, Titan and HAL. Compare market cap, PE, ROE and growth."],"rank_math_focus_keyword":["stocks valued between Rs 3 and Rs 5 lakh crore"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-largecap-stocks-valued-between-rs-3-and-rs-5-lakh-crore-to-watch-for-future.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/319380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=319380"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/319380\/revisions"}],"predecessor-version":[{"id":319381,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/319380\/revisions\/319381"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/319379"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=319380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=319380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=319380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}